Mercer Global Advisors
BNTX icon

Mercer Global Advisors’s BioNTech BNTX Stock Holding History

Mercer Global Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,858
Closed -$223K – 2130
2024
Q3 		$223K Sell
1,858
-1,425
-43% -$131K ﹤0.01% 1758
2024
Q2 		$264K Sell
3,283
-6,272
-66% -$573K ﹤0.01% 1644
2024
Q1 		$881K Buy
9,555
+884
+10% +$84.8K ﹤0.01% 1024
2023
Q4 		$915K Buy
8,671
+930
+12% +$93.7K ﹤0.01% 1014
2023
Q3 		$841K Buy
7,741
+2,074
+37% +$229K ﹤0.01% 1013
2023
Q2 		$612K Sell
5,667
-104
-2% -$11.7K ﹤0.01% 1138
2023
Q1 		$719K Sell
5,771
-513
-8% -$70.4K ﹤0.01% 1038
2022
Q4 		$944K Buy
6,284
+598
+11% +$92K ﹤0.01% 940
2022
Q3 		$767K Buy
5,686
+597
+12% +$91.3K ﹤0.01% 962
2022
Q2 		$759K Buy
5,089
+1,041
+26% +$159K ﹤0.01% 955
2022
Q1 		$690K Buy
4,048
+764
+23% +$128K ﹤0.01% 1069
2021
Q4 		$847K Buy
3,284
+2,538
+340% +$695K 0.01% 959
2021
Q3 		$204K Sell
746
-292
-28% -$92.8K ﹤0.01% 1610
2021
Q2 		$232K Buy
+1,038
New +$196K ﹤0.01% 1497

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Mercer Global Advisors's BNTX Position: Q4 2024 in Review

Mercer Global Advisors sold out of BioNTech (BNTX) in Q4 2024, closing a stake of 1,858 shares — an estimated $223K sold.

Mercer Global Advisors first reported a position in BNTX in Q2 2021 and held it in 14 quarters. The position peaked at $944K in Q4 2022. 303 funds tracked by Wall St. Rank hold BNTX as of Q4 2024.

  • Mercer Global Advisors reported no remaining BioNTech position as of Q4 2024 after selling out during the quarter.
  • Mercer Global Advisors sold 1,858 BioNTech shares in Q4 2024, an estimated $223K.
  • Mercer Global Advisors first reported a position in BioNTech in Q2 2021 and held it in 14 quarters.
  • Mercer Global Advisors's BioNTech position peaked at $944K in Q4 2022.
  • 303 funds tracked by Wall St. Rank held BioNTech as of Q4 2024.

Based on Mercer Global Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.